RE: Over 50,000021 Oct 2021 17:51
Abbott and Roche both see strong demand for PCR testing into 2022. Novacyt announce September as the best trading month in the companys history. I would suspect a bullish update is due. They have reiterated the £100m revenue guidance for this year but could well exceed that depending how well Q4 does. We rather under promise over deliver. fundamentals always come through in the end. If the market is not reacting to this then it creates a buying opportunity.